A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
Long-Term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response
Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C
Short-Term Histological Evaluations After Achieving a Sustained Virologic Response to Direct-Acting Antiviral Treatment for Chronic Hepatitis C
Vitamin D Level and Sustained Virologic Response to Interferon-Based Antiviral Therapy in Chronic Hepatitis C: A Systematic Review and Meta-Analysis
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C
Sustained Virologic Response by Direct Antiviral Agents Reduces the Incidence of Hepatocellular Carcinoma in Patients With HCV Infection
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
A Randomized, Controlled Trial to Determine Whether Continued Ribavirin Monotherapy in Hepatitis C Virus-Infected Patients Who Responded to Interferon-Ribavirin Combination Therapy Will Enhance Sustained Virologic Response.
